ReviewCell death discovery2025
Dual role mechanisms of regulated cell death in apical periodontitis: from pathogenic destruction to therapeutic potential.
Review in Cell death discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Network Toxicology and Molecular Docking Analysis of Targets and Potential Mechanisms of PEEK-Induced Bone Resorption.International journal of molecular sciences · 2026Article
- Comparative Molecular Effects of Dexmedetomidine and Propofol on Osteoblast Migration and Osteogenic Gene Expression at Pediatric-Equivalent Concentrations: An In Vitro Study.Current issues in molecular biology · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Apical periodontitis (AP), a highly prevalent infectious disease driven by pathogenic microorganisms residing in periapical tissues, orchestrates a dynamic interplay between microbial virulence and host immune defenses. Emerging evidence indicates that these pathogens critically manipulate regulated cell death (RCD) pathways to subvert immune surveillance and dictate periapical bone remodeling outcomes. While RCD has traditionally been viewed as a dichotomy between pro-inflammatory destruction and anti-inflammatory repair, recent advances reveal its context-dependent duality, shaped by microbial-immune crosstalk. Despite growing interest in this field, current literature lacks a comprehensive synthesis delineating the dual-pathological impact of RCD mechanisms in AP progression, particularly their beneficial versus detrimental roles. This review critically evaluates the molecular mechanisms of RCD and crosstalk among its forms, delineating its dual roles in immune defense versus bone destruction during AP progression. We synthesize current understanding of RCD pathways in AP pathogenesis and explore therapeutically targeting these mechanisms to modulate disease outcomes. Furthermore, we explore the feasibility of developing therapeutic strategies for AP based on RCD targets and propose novel research directions to advance understanding and treatment of this condition.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.